Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » Share your VHL story with PBAC to list Belzutifan on the PBS

Share your VHL story with PBAC to list Belzutifan on the PBS

  • April 10, 2024

Help improve the lives of patients living with Von Hippel-Lindau (VHL) in Australia.

Submissions close 29th of May, 2024. Share your VHL story today.
  • Are you a VHL patient, a healthcare professional, or a carer of someone living with VHL?
  • Are you a member of the general public who has seen how VHL impacts quality of life?
  • Are you happy to share your story and how VHL has impacted your lived experiences? 
If you answered yes to ANY of the above questions, we need your help.

The Pharmaceuticals Benefits Advisory Committee (PBAC) is set to consider the potential listing of Belzutifan at their upcoming meeting in July 2024. Your input as a VHL patient, carer, a member of the general public, or HCP is invaluable in this decision-making process.

The PBAC will assess clinical evidence but also welcomes supporting submissions from doctors, healthcare professionals, patients, and carers. Your voice can profoundly influence decision-makers, shedding light on the real impact of innovative treatments for VHL patients. Consumer comments matter – and we need yours.

How can you help?

Submit your personal story via the instructions below. 

Patient and carer input, in the form of short personal narratives, can greatly aid the PBAC in understanding the lived experiences of those affected by VHL. Your stories are instrumental in shaping the PBAC’s decision-making process.

Submission Deadline.

The closing date for patient comments is 29th May 2024 and submissions can be made as follows:

Online Submission

Submit via the online portal https://ohta-consultations.health.gov.au/ohta/pbac-july-2024/

Email Submission

Email your input directly to the PBAC at CommentsPBAC@health.gov.au; or,

Mail Submission

Mail your submission to the PBAC Secretariat: MDP 952, Department of Health and Ageing, GPO Box 9848, Canberra ACT 2601

Invite your local MP to the VHL Parliament Event.

NECA is organising a special VHL event at Parliament House in Canberra, with the support of MSD. This event, scheduled for Thursday, 4th July from 10 am to 12 midday, aims to raise awareness and garner support for the VHL cause. All MPs and Senators will receive invitations, and your participation is key. We encourage you to reach out to your local MP and request their attendance.

Your participation and advocacy are pivotal in ensuring access to life-changing treatments for VHL patients. Together, let’s make our voices heard and pave the way for a brighter future.

Need more information?

 The Patient Voice Initiative has a range of practical resources including:

  • Short guides for health consumers and their loved ones who are interested in making a consumer comment
  • A tip sheet by an experienced patient advocate can be downloaded and shared.

Share this post

Recent posts

International Nurses Day 2025

May 12, 2025

VHL Awareness Month 2025

May 6, 2025

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

May 5, 2025

Help Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact

April 29, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousAPPIS (Alliance & Partnership for Patient Innovation and Solutions) Summit 2024
NextNECA supports VHL patients Australia wide as they lobby for Belzutifan to be included on PBSNext

Related Posts

International Nurses Day 2025

🌏International Nurses Day 🌏 From providing support to NET patients via our specialist NET Nurse service, to running educational forums for patients or HCPs, the

VHL Awareness Month 2025

May is internationally recognised as Von Hippel-Lindau (VHL) Awareness Month—a time to highlight this rare genetic, and in some case not genetic, condition and the

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

Jo O’Halloran was in her early fifties when the symptoms she and her friends had heard so much about started to appear. ‘I was always

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin